Boulder Hill Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,400	Closed	-$522K	–	152
2022 Q4	$522K	Buy	+11,400	New	+$522K	0.43%	56